Advertisement

Related Videos

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Opportunities to Optimize Cancer Policies Panel Discussion

Peter Clark, MA, MD, FRCP: A Payer Perspective

Varsha Gandhi, PhD, on Ibrutinib

Advertisement

Advertisement




Jul
31
Today In Oncology
Rectal Cancer AI Identifies Patients Most Likely to Benefit From Irinotecan-Intensified Neoadjuvant Chemoradiotherapy
Beth Erickson, MD, FASTRO, Named ASTRO President-Elect
Monica Baskin Named Director of VCU Massey Comprehensive Cancer Center
Case Series Supports High-Dose Oral Vitamin D for Cancer Therapy–Related Skin Toxicities
MRI-Based T Staging Matches Traditional Clinical Staging in Localized Prostate Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo